BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24315438)

  • 21. Fraudsters operate and officialdom turns a blind eye: a proposal for controlling stem cell therapy in China.
    Jiang L; Dong BH
    Med Health Care Philos; 2016 Sep; 19(3):403-10. PubMed ID: 26906907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell tourism and future stem cell tourists: policy and ethical implications.
    Einsiedel EF; Adamson H
    Dev World Bioeth; 2012 Apr; 12(1):35-44. PubMed ID: 22420450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New regulation for clinical stem cell research in China: expected impact and challenges for implementation.
    Rosemann A; Sleeboom-Faulkner M
    Regen Med; 2016 Jan; 11(1):5-9. PubMed ID: 26680327
    [No Abstract]   [Full Text] [Related]  

  • 24. The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions.
    Ogbogu U; Du J; Koukio Y
    BMC Med Ethics; 2018 May; 19(1):32. PubMed ID: 29716594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell treatments raise thorny questions for researchers, clinicians.
    Hede K
    J Natl Cancer Inst; 2012 Mar; 104(5):347-9. PubMed ID: 22349201
    [No Abstract]   [Full Text] [Related]  

  • 26. The Food and Drug Administration, regenerative sciences, and the regulation of autologous stem cell therapies.
    von Tigerstrom B
    Food Drug Law J; 2011; 66(4):479-506, i. PubMed ID: 24505826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem Cells: Flexible friends.
    Shevde N
    Nature; 2012 Feb; 483(7387):S22-6. PubMed ID: 22378125
    [No Abstract]   [Full Text] [Related]  

  • 28. Alternative sources of adult stem cells: a possible solution to the embryonic stem cell debate.
    Moore KE; Mills JF; Thornton MM
    Gend Med; 2006 Sep; 3(3):161-8. PubMed ID: 17081949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vulnerabilities and the Use of Autologous Stem Cells for Medical Conditions in Australia.
    Hendl T
    Perspect Biol Med; 2018; 61(1):76-89. PubMed ID: 29805149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Issue calls for reasoned discussion, not politics.
    Joyce JJ
    Minn Med; 2011 Jun; 94(6):5. PubMed ID: 21736194
    [No Abstract]   [Full Text] [Related]  

  • 31. [Report of the Central Ethics Committee for Stem Cell Research (ZES): Eleventh Report of entry into enforcement of the Stem Cell Act (StZG) for the period from 01.01.2013 to 31.12.2013].
    Zentrale Ethik-Kommission für Stammzellforschung
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jul; 57(7):903-9. PubMed ID: 25089308
    [No Abstract]   [Full Text] [Related]  

  • 32. Adult stem cell therapies walk the line.
    DeFrancesco L
    Nat Biotechnol; 2012 Aug; 30(8):739-41. PubMed ID: 22871705
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparing national home-keeping and the regulation of translational stem cell applications: An international perspective.
    Sleeboom-Faulkner M; Chekar CK; Faulkner A; Heitmeyer C; Marouda M; Rosemann A; Chaisinthop N; Chang HC; Ely A; Kato M; Patra PK; Su Y; Sui S; Suzuki W; Zhang X
    Soc Sci Med; 2016 Mar; 153():240-9. PubMed ID: 26921839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous transplantation in the central nervous system.
    Taupin P
    Indian J Med Res; 2006 Dec; 124(6):613-8. PubMed ID: 17287548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global bionetworks and challenges in regulating autologous adult stem cells.
    Lysaght T; Kerridge I; Sipp D; Porter G; Capps BJ
    Am J Med; 2013 Nov; 126(11):941-3. PubMed ID: 24157285
    [No Abstract]   [Full Text] [Related]  

  • 36. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International stem cell tourism and the need for effective regulation. Part II: Developing sound oversight measures and effective patient support.
    Cohen CB; Cohen PJ
    Kennedy Inst Ethics J; 2010 Sep; 20(3):207-30. PubMed ID: 21133333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult periodontal-derived neural progenitor and stem cells. Institut fur Molekulare Diagnostik und Innovative Therapie: WO2008031451.
    Taupin P
    Expert Opin Ther Pat; 2009 May; 19(5):715-9. PubMed ID: 19441943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The need for international stem cell agreements.
    Resnik DB
    Nat Biotechnol; 2004 Oct; 22(10):1207. PubMed ID: 15470449
    [No Abstract]   [Full Text] [Related]  

  • 40. Law, ethics, religion, and clinical translation in the 21st century--a discussion with John Sinden.
    Lako M; Trounson A; Daher S
    Stem Cells; 2010 Jan; 28(1):3-4. PubMed ID: 19998371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.